Brain mercury in neurodegenerative disorders

Yiu K. Fung, Andrew G. Meade, Edward P. Rack, Alan J. Blotcky

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

Background: Trace element neurotoxicity has long been invoked as an etiologic factor for Alzheimer's disease. This study was conducted to determine the concentrations of mercury in seven different brain regions from deceased patients histologically confirmed with Alzheimer's disease or multiple sclerosis as compared to control subjects without known central nervous system and renal disorders. Brain mercury concentrations in all deceased subjects can arise from amalgam restorations, diet, and the working environment. Methods: Autopsy frozen specimens (control, Alzheimer's disease and multiple sclerosis) from seven brain regions, which included frontal cortex, temporal cortex, occipital cortex, putamen, hippocampus, corona radiata and corpus callosum were assayed for the concentrations of selenium using instrumental neutron activation analysis and mercury using radiochemical neutron activation analysis. Results: We found that the concentrations of mercury and the mercury/selenium molar ratios were significantly lower in the hippocampi of multiple sclerosis patients as compared to aged-matched controls. However, no statistically significant differences were detected for the concentrations of mercury and the mercury/selenium molar ratios for the remaining six brain regions among these groups. Conclusions: Since brain mercury concentrations from deceased subjects with either Alzheimer's disease or multiple sclerosis are not significantly higher than controls, the present study provides no scientific support that mercury plays a significant role in the pathogenesis of these neurologic disorders.

Original languageEnglish (US)
Pages (from-to)49-54
Number of pages6
JournalJournal of Toxicology - Clinical Toxicology
Volume35
Issue number1
DOIs
StatePublished - Jan 1 1997

Fingerprint

Mercury
Neurodegenerative Diseases
Brain
Alzheimer Disease
Multiple Sclerosis
Selenium
Neutron Activation Analysis
Neutron activation analysis
Hippocampus
Disease control
Mercury amalgams
Occipital Lobe
Corpus Callosum
Putamen
Central Nervous System Diseases
Trace Elements
Neurology
Frontal Lobe
Temporal Lobe
Nutrition

ASJC Scopus subject areas

  • Toxicology
  • Health, Toxicology and Mutagenesis

Cite this

Brain mercury in neurodegenerative disorders. / Fung, Yiu K.; Meade, Andrew G.; Rack, Edward P.; Blotcky, Alan J.

In: Journal of Toxicology - Clinical Toxicology, Vol. 35, No. 1, 01.01.1997, p. 49-54.

Research output: Contribution to journalArticle

Fung, Yiu K. ; Meade, Andrew G. ; Rack, Edward P. ; Blotcky, Alan J. / Brain mercury in neurodegenerative disorders. In: Journal of Toxicology - Clinical Toxicology. 1997 ; Vol. 35, No. 1. pp. 49-54.
@article{99da67957c0d4e08ba88e04b6de4b3cd,
title = "Brain mercury in neurodegenerative disorders",
abstract = "Background: Trace element neurotoxicity has long been invoked as an etiologic factor for Alzheimer's disease. This study was conducted to determine the concentrations of mercury in seven different brain regions from deceased patients histologically confirmed with Alzheimer's disease or multiple sclerosis as compared to control subjects without known central nervous system and renal disorders. Brain mercury concentrations in all deceased subjects can arise from amalgam restorations, diet, and the working environment. Methods: Autopsy frozen specimens (control, Alzheimer's disease and multiple sclerosis) from seven brain regions, which included frontal cortex, temporal cortex, occipital cortex, putamen, hippocampus, corona radiata and corpus callosum were assayed for the concentrations of selenium using instrumental neutron activation analysis and mercury using radiochemical neutron activation analysis. Results: We found that the concentrations of mercury and the mercury/selenium molar ratios were significantly lower in the hippocampi of multiple sclerosis patients as compared to aged-matched controls. However, no statistically significant differences were detected for the concentrations of mercury and the mercury/selenium molar ratios for the remaining six brain regions among these groups. Conclusions: Since brain mercury concentrations from deceased subjects with either Alzheimer's disease or multiple sclerosis are not significantly higher than controls, the present study provides no scientific support that mercury plays a significant role in the pathogenesis of these neurologic disorders.",
author = "Fung, {Yiu K.} and Meade, {Andrew G.} and Rack, {Edward P.} and Blotcky, {Alan J.}",
year = "1997",
month = "1",
day = "1",
doi = "10.3109/15563659709001165",
language = "English (US)",
volume = "35",
pages = "49--54",
journal = "Clinical Toxicology",
issn = "1556-3650",
publisher = "Informa Healthcare",
number = "1",

}

TY - JOUR

T1 - Brain mercury in neurodegenerative disorders

AU - Fung, Yiu K.

AU - Meade, Andrew G.

AU - Rack, Edward P.

AU - Blotcky, Alan J.

PY - 1997/1/1

Y1 - 1997/1/1

N2 - Background: Trace element neurotoxicity has long been invoked as an etiologic factor for Alzheimer's disease. This study was conducted to determine the concentrations of mercury in seven different brain regions from deceased patients histologically confirmed with Alzheimer's disease or multiple sclerosis as compared to control subjects without known central nervous system and renal disorders. Brain mercury concentrations in all deceased subjects can arise from amalgam restorations, diet, and the working environment. Methods: Autopsy frozen specimens (control, Alzheimer's disease and multiple sclerosis) from seven brain regions, which included frontal cortex, temporal cortex, occipital cortex, putamen, hippocampus, corona radiata and corpus callosum were assayed for the concentrations of selenium using instrumental neutron activation analysis and mercury using radiochemical neutron activation analysis. Results: We found that the concentrations of mercury and the mercury/selenium molar ratios were significantly lower in the hippocampi of multiple sclerosis patients as compared to aged-matched controls. However, no statistically significant differences were detected for the concentrations of mercury and the mercury/selenium molar ratios for the remaining six brain regions among these groups. Conclusions: Since brain mercury concentrations from deceased subjects with either Alzheimer's disease or multiple sclerosis are not significantly higher than controls, the present study provides no scientific support that mercury plays a significant role in the pathogenesis of these neurologic disorders.

AB - Background: Trace element neurotoxicity has long been invoked as an etiologic factor for Alzheimer's disease. This study was conducted to determine the concentrations of mercury in seven different brain regions from deceased patients histologically confirmed with Alzheimer's disease or multiple sclerosis as compared to control subjects without known central nervous system and renal disorders. Brain mercury concentrations in all deceased subjects can arise from amalgam restorations, diet, and the working environment. Methods: Autopsy frozen specimens (control, Alzheimer's disease and multiple sclerosis) from seven brain regions, which included frontal cortex, temporal cortex, occipital cortex, putamen, hippocampus, corona radiata and corpus callosum were assayed for the concentrations of selenium using instrumental neutron activation analysis and mercury using radiochemical neutron activation analysis. Results: We found that the concentrations of mercury and the mercury/selenium molar ratios were significantly lower in the hippocampi of multiple sclerosis patients as compared to aged-matched controls. However, no statistically significant differences were detected for the concentrations of mercury and the mercury/selenium molar ratios for the remaining six brain regions among these groups. Conclusions: Since brain mercury concentrations from deceased subjects with either Alzheimer's disease or multiple sclerosis are not significantly higher than controls, the present study provides no scientific support that mercury plays a significant role in the pathogenesis of these neurologic disorders.

UR - http://www.scopus.com/inward/record.url?scp=0031042131&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031042131&partnerID=8YFLogxK

U2 - 10.3109/15563659709001165

DO - 10.3109/15563659709001165

M3 - Article

C2 - 9022652

AN - SCOPUS:0031042131

VL - 35

SP - 49

EP - 54

JO - Clinical Toxicology

JF - Clinical Toxicology

SN - 1556-3650

IS - 1

ER -